Shangying Hu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center · ORCID：0000-0002-4778-1612

发表论文 263 篇 · 总被引 2923 次 · h-index 30

代表论文

• Informing HPV vaccine pricing for government-funded vaccination in mainland China: a modelling study (2024 · The Lancet Regional Health - Western Pacific · 被引 11)
• The variations in the natural history of high‐risk human papillomavirus infections in Chinese healthy women aged 27–45 years compared with 18–26 years: A prospective cohort study (2024 · International Journal of Cancer · 被引 6)
• Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort (2025 · The Lancet Regional Health - Western Pacific · 被引 4)
• The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age (2024 · Human Vaccines & Immunotherapeutics · 被引 4)
• Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling study (2025 · The Lancet Regional Health - Western Pacific · 被引 2)
• Long-term protective efficacy of the Escherichia coli-produced HPV-16/18 bivalent human papillomavirus vaccine in women vaccinated at 18–45 years: A 9-year follow-up study (2025 · Infectious Medicine · 被引 2)